Skip to main content


Monday, January 11, 2016
McGovern incubator embraces Embark and Ecolectro

To kick off the new year, Cornell’s Kevin M. McGovern Family Center for Venture Development in the Life Sciences welcomed two startup companies to its incubator space Jan. 7: Ecolectro, which aims to make cost-effective, renewable energy technology, and Embark Veterinary, which seeks to apply a new canine genetic testing platform to help keep dogs healthy.
Read more ...

Wednesday, November 04, 2015
McGovern Center named among Top 10 North American Univ. Incubators for 2015

UBI Global ranked Cornell's McGovern Center Number 9 on their 2015 “North American Top 10 University Business Incubator” list. UBI Global is a Swedish company that collects, analyzes, normalizes and presents standardized performance metrics for business incubation programs worldwide. UBI Global collects data from over 1000 business incubator programs around the world and this year over 400 incubators were ranked. Lou Walcer traveled to Toronto, Canada on November 3, 2015 to


Thursday, April 23, 2015
Skin-repair startup joins McGovern Center incubator

By all rights, the April 17 ceremony – welcoming startup company Repairogen to Cornell’s incubator for life sciences, the Kevin M. McGovern Family Center for Venture Development – should have been outdoors, in the full glare of the skin-damaging sun.
Read more ...

Friday, January 09, 2015
Movin' on up: Startup 'graduates' from McGovern incubator

Bolstered by a $2.3 million venture capital investment, an agricultural technology startup is moving on from its first home in Cornell’s life sciences business incubator, a little more than a year after it arrived.
Read more ...

Wednesday, November 05, 2014
Cornell startup ZYMtronix partners with enzyme company

ZYMtronix, a startup company with roots in Cornell-developed technology and operating in Cornell’s Kevin M. McGovern Center for Venture Development, has signed an agreement with Codexis, a major producer of pharmaceutical enzymes in Redwood City, California.
Read more ...

Tuesday, February 18, 2014
Pathogen-testing firm keys into McGovern Center

With door keys in hand and research ready for a scientific bench, startup business Ionica Sciences became the newest tenant Feb. 5 at Cornell’s Kevin M. McGovern Family Center for Venture Development in the Life Sciences.

Ionica Sciences produces adaptable, sensitive and easy-to-use biological assays that can detect hard-to-discern infectious diseases, toxins and other biological molecules. The group uses surface-enhanced Raman scattering, known as SERS-based detection to find errant


Monday, January 27, 2014
New York's Designation of "Innovation Hot Spots"

New York State's designation of 'Innovation Hot Spots' and 'Certified Incubators' favored BIA/NYS members with solid histories of accomplishment and well designed operating plans.

Wednesday, November 20, 2013
New program aims to commercialize Cornell technology

Think (scientific) soup to (commercial) nuts: To provide a corporate leg up to technology opportunities and startup companies emerging from research here, the new Cornell Technology Acceleration and Maturation (C-TAM) program is designed to propel promising ideas toward commercial viability.

“C-TAM is a bridge from the status quo of bench research to licensable technologies and investable baby companies,” said Lou Walcer, director of Cornell’s Kevin M. McGovern Family Center


Thursday, October 24, 2013
With incubator’s help, ArcScan may see clear success

ArcScan, which signed on as the newest tenant Oct. 15 at Cornell’s Kevin M. McGovern Family Center for Venture Development incubator, becomes the first company there whose medical device was developed at Weill Cornell Medical College (WCMC) in New York City. ArcScan’s Artemis III is an ultra-high resolution ultrasound ophthalmic diagnostic instrument that maps a patient’s eye in comprehensive three-dimensional images – which helps opthalmic surgeons identify potential …

Wednesday, October 23, 2013
Incubating a new business at Cornell

ITHACA At a time when politicians, practitioners and insurance companies are scrounging around the health care system for ways to save money, a budding Ithaca company is gearing up to radically reduce the cost of many medications.

Scientists at biotech startup Glycobia have invented a method to manufacture glycoprotein drugs, which are used to treat a wide array of diseases, ranging from cancer to multiple sclerosis to rare genetic diseases. Through genetic engineering, the researchers are


Friday, February 15, 2013
McGovern Center names three executives in residence

Three new executives in residence, charged with facilitating commercialization of Cornell technologies, have joined the staff of the Kevin M. McGovern Family Center for Venture Development in the Life Sciences.

Jonathan Greene, Edward Heslop and William Rhodes III began their appointments Feb. 7 at the center, which is an early-stage life sciences company incubator located in Weill Hall.

“These are exquisitely talented individuals,” said McGovern Center Director Lou Walcer. “